Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

PKI - Revvity Inc.


Previous close
115.22
115.220   100.000%

Share volume: 0
Last Updated: Mon 15 May 2023 08:01:03 PM CEST
Analytical Laboratory Instrument Manufacturing : -7.53%

PREVIOUS CLOSE
CHG
CHG%

N/A
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
79%
Profitability 100%
Dept financing 50%
Liquidity 59%
Performance 70%
Company vs Stock growth
vs
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
-3.82%
6 Months
-3.26%
1 Year
-3.26%
2 Year
-13.60%
Key data
Stock price
$115.22
P/E Ratio 
15.03
DAY RANGE
N/A - N/A
EPS 
$7.61
52 WEEK RANGE
$117.76 - $128.15
52 WEEK CHANGE
-$3.26
MARKET CAP 
14.456 B
YIELD 
0.24%
SHARES OUTSTANDING 
125.441 M
DIVIDEND
$0.07
EX-DIVIDEND DATE
04/20/2023
NEXT EARNINGS DATE
N/A
BETA 
1.13
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Prahlad Singh
Region: US
Website: www.perkinelmer.com
Employees: 16,700
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Analytical Laboratory Instrument Manufacturing
Sector: Manufacturing

PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.

Recent news